by Prashant Kesharwani (Author)
Drug Discovery Targeting Drug-Resistant Bacteria explores the status and possible future of developments in fighting drug-resistant bacteria. The book covers the majority of microbial diseases and the drugs targeting them. In addition, it discusses the potential targeting strategies and innovative approaches to address drug resistance. It brings together academic and industrial experts working on discovering and developing drugs targeting drug-resistant (DR) bacterial pathogens. New drugs active against drug-resistant pathogens are discussed, along with new strategies being used to discover molecules acting via new modes of action. In addition, alternative therapies such as peptides and phages are included.
Pharmaceutical scientists, microbiologists, medical professionals, pathologists, researchers in the field of drug discovery, infectious diseases and microbial drug discovery both in academia and in industrial settings will find this book helpful.
Written by scientists with extensive industrial experience in drug discovery Provides a balanced view of the field, including its challenges and future directions Includes a special chapter on the identification and development of drugs against pathogens which exhibit the potential to be used as weapons of war
Product Details
Publisher: Elsevier Science; May 15, 2020
Language: English
ISBN: 9780128184806
ISBN: 9780128184813

Practical Manual of Histology (PDF)
Telemedicine and Electronic Medicine
Essentials of Nuclear Medicine Imaging 6th
Safety Concerns for Herbal Drugs
Goodman and Gilman's The Pharmacological Basis of Therapeutics, 12th Edition
Lippincott's Concise Illustrated Anatomy: Volume 2: Thorax, Abdomen & Pelvis
Paediatric Dentistry: Principles and Practice, 2nd Edition (PDF)
The Licensing Exam Review Guide in Nursing Home Administration, Seventh Edition
Neurological Emergencies in Clinical Practice (EPUB)
Diagnostic Electron Microscopy: A Practical Guide to Interpretation and Technique 1st Edition 
Reviews
There are no reviews yet.